TCT 408: Outcomes of High vs Low Volume Retrograde Chronic Total Occlusion Percutaneous Coronary Intervention Operators: Insights From the PROGRESS-CTO Registry

Within the prior 24 months, I have had a financial relationship with a company producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients:

• Consultant Fee/Honoraria/Speaker’s Bureau - Boston Scientific Corporation; Abiomed
• Consultant Fee/Honoraria/Speaker's Bureau - Electroducer